Onychomycosis Market

Company Headquarters: Haifa Bay, Israel Founded: 1959 Workforce: ~1,490 Company Working: Taro Pharmaceuticals Industries Ltd is a research-based, international, specialty pharmaceutical company that develops, manufactures, and markets prescription and over the counter (OTC) pharmaceutical products. The company offers its products primarily in the areas of topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, anti-inflammatory, and other therapeutic categories.

Company Headquarters: Bromma, Sweden Founded: 2006 Company Working: Moberg Pharma AB develops patented topical pharmaceuticals for the treatment of common disorders through the use of innovative drug delivery. The company comprises only one area of operation, which is the development and commercialization of medical products. MOB-015 is the next generation of nail fungus treatment and BUPI is a new pain treatment for mouth and throat for cancer patients with oral mucositis. MOB-015 is currently undergoing two parallel phase 3 studies with expected topline results towards the end of 2019 and the second quarter of 2020, respectively. It has also signed two license agreements with leading players in Europe and Canada. It markets its products directly in the US, as well as through a network of distributors in approximately 40 countries.

Company Headquarters: Frankfurt, Germany Founded: 1908 Workforce: ~3,151 Company Working: Merz Pharma is a global aesthetic and neurotoxin company that has strong research and development capabilities. Its aesthetic products are renowned for their extraordinary quality and outstanding results. The company aims to achieve and discover the needs of specialists and work in line to help patients achieve their desired results. Merz Aesthetics' portfolio is expanded and its position in the aesthetic medicine industry is strengthened by the integration of Anteis' operations into its own. Moreover, the company operates in fields such as neurology, Over The Counter (OTC) medicines, dietary supplements, and skincare products. The company is directly present in more than 34 countries and offers its products in around 90 countries.

Company Headquarters: New Jersey, US Founded: 1886 Workforce: ~130,000 Company Working: Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. Ethicon manufactures sutures, endocutters, breast care products, and energy-based products, like hand instruments, for tissue dissection. In 2016, Ethicon acquired NeuWave Medical, Inc.Johnson & Johnson is the world’s largest and broadly based healthcare company. It engages in the R&D, manufacture, and sale of products in the healthcare field. I Its pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, oncology, cardiovascular and metabolism, and pulmonary hypertension t has more than 130 years of industry experience. The company has a team of 134,000 people at 260 companies in more than 60 countries around the globe.

Established in 1981 and headquarters in Lausanne, Switzerland. Galderma is one of the big names of the pharmaceutical industry in dermatology, over the past three decades galderma key area of focus is to provide innovative solutions in the field of dermatology, which consists of acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and other various fields in skin care. Currently Galderma is a global leader in dermatology and has strategic partnerships with brands like Soolantra, Tri-Luma, Loceryl, BenzacEpiduo, Oracea, Differin, Mirvaso, Cetaphil, Excipial, Daylong, Restylane, Emervel and many other brands. Presently galderma is operating in over 80+ countries, providing patients with skin care needs and has an employee work force of over 6000 employees. The company has worldwide network of distributers and 34 wholly-owned affiliates.

Company Headquarters: Hyderabad, India Founded: 1984 Workforce: 20,000+ Company Working: Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthy lives. Through its three businesses, namely, pharmaceutical services and active ingredients, global generics, and proprietary products Dr. Reddy’s offers a portfolio of products and services including active pharmaceutical ingredients (API), custom pharmaceutical services, generics, biosimilars, and differentiated formulations. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. It operates in markets across the US, India, Russia, Commonwealth of Independent States (CIS) countries, and Europe.